Clinical trial
Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques
NCT06957821 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- December 31, 2029
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.